3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
86
Recurrence
18
Neoplasms
6
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Sarcoma, Kaposi
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Chromosome 17 deletion
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Smoldering Multiple Myeloma
1
Proteostasis Deficiencies
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Chronic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Epstein-Barr Virus Infections
1
Interventions
Cyclophosphamide
14
Temozolomide
11
Vincristine
9
Magnetic Resonance Spectroscopy
9
Cisplatin
9
Etoposide
8
Specimen Handling
7
Radiotherapy
7
X-Rays
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Lomustine
5
Carboplatin
5
Methotrexate
4
Irinotecan
4
Biopsy
4
etoposide phosphate
3
Thiotepa
3
Radiation
3
Platinum
3
Nivolumab
3
Filgrastim
3
Celecoxib
3
Bevacizumab
3
Automobiles
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
pomalidomide
×
1 year
×
Clear all
No trials found.